FDA Investigator: Scott A. Golladay

- Scott A. Golladay first started conducting FDA inspections in 2016, with the last inspection in 2020. Over that time, Scott A. Golladay has conducted 30 inspections at 24 companies across 28 sites.

Get Scott Golladay's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 3M Healthcare Business, Saint Paul | 2020

Out-of-stock
Scott A. Golladay
Human Drug Form 483

FDA 483 Takeda Pharmaceuticals U.S.A., Brooklyn Park | 2020

Out-of-stock
Scott A. Golladay
Human Drug Form 483

FDA 483 Shalem Products Inc, Angora | 2019

Out-of-stock
Scott A. Golladay
Human Drug Form 483

FDA 483 Weckerle Cosmetics Eislingen GmbH, Eislingen/Fils | 2019

Out-of-stock
Scott A. Golladay
Human Drug Form 483

FDA 483 Upsher Smith Laboratories, Inc., Maple Grove | 2018

Out-of-stock
Scott A. Golladay
Human Drug Form 483

FDA 483 Diversified Manufacturing Corporation, Prescott | 2018

Out-of-stock
Scott A. Golladay
Animal Drugs & Feed Form 483

FDA 483 Pharmacia & Upjohn Company LLC, Kalamazoo | 2018

Out-of-stock
Scott A. Golladay
Animal Drugs & Feed Form 483

FDA 483 3M Company, Brookings | 2018

Out-of-stock
Scott A. Golladay
Human Drug Form 483

FDA 483 Pace Analytical Life Sciences, LLC, Oakdale | 2018

Out-of-stock
Scott A. Golladay
Human Drug Form 483

FDA 483 CELL CULTURE COMPANY LLC, Minneapolis | 2017

Out-of-stock
Scott A. Golladay
Human Drug Form 483